Jacobs Medical Center is a teaching hospital on the University of California, San Diego campus in the La Jolla neighborhood of San Diego.

There are 364 beds in UCSD Medical Center.

During the past decade, UCSD Medical Center conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 27 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 15 clinical trials were completed. i.e. 187.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSD Medical Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Actelion" with 4 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored and "University of California, San Diego" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSD Medical Center" #1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator and "National Marrow Donor Program" with 3 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "UCSD Medical Center" are "Pulmonary Arterial Hypertension" (10 trials), "COVID-19" (4 trials), "Chronic Pain" (4 trials), "Crohn Disease" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "UCSD Medical Center" in a lesser frequency.

Most popular intervention types in "UCSD Medical Center" are "Drug" (39 trials), "Other" (10 trials), "Device" (9 trials), "Biological" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Remdesivir" (4 trials), "Ozanimod" (3 trials), "Baricitinib" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Medical Center" are 51 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "UCSD Medical Center". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in UCSD Medical Center, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Medical Center, 5 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".